Numinus CEO Discussion: a LEADER in Psychedelic-Assisted Therapy? ( NUMI / LKYSF Stock)

(31:6)

Numinus CEO on Potential Psychedelic Run

(37:7)

Numinus CEO: Psychedelics Benefit From \

(19:2)

Numinus CEO Payton Nyquvest talks Psychedelics and Mental Health

(3:54)

Numinus CEO Payton Nyquvest at Psychedelic Capital, Oct 2020 | Microdose

(14:52)

Numinus Wellness CEO Discusses MAPS Partnership \u0026 How Psychedelics Will Change Society

(19:19)

Numinus Inc.CEO Talks NASDAQ Ambitions

(17:22)

Numinus At The Forefront of MDMA | Payton Nyquvest - CEO Numinus Wellness

(16:5)

The Entities that Exist Within Psychedelics | With Dennis McKenna

(12:41)

Psychedelics, stigma, science and startups | High Agency | Episode 13

(59:3)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

SPOTLIGHT IN FOCUS - The Rise of Psychedelic Therapy

(33:13)

What Are Psychedelics?

(3:34)

BC Decriminalizes Hard Drugs | Trade To Black

(39:21)

CYBIN CEO Doug Drysdale On How CYB-003 Is Better Than Psilocybin | Next Gen Psychedelics

(8:4)

BREAKING NEWS: MAPS Publishes Phase 3 PTSD Results | The Dales Report

(33:10)

Upcoming Catalysts in the Industry Explained - TDR Exclusive

(34:32)

Numinus Wellness to Acquire Novamind: An Interview with Numinus Co-Founder and CEO, Payton Nyquvest

(17:30)

Numinus CEO Discusses Latest Earnings - TDR Exclusive

(20:59)

A Magic Mushroom Company to be Psyched About | Numinus Wellness(NUMI)

(11:21)

Numinus CEO: Current State of Psychedelic Industry

(26:46)

EXCLUSIVE shareholder webinar with Numinus Wellness Founder and CEO Payton Nyquvest

(50:7)

Numinus CEO, Payton Nyquvest, on chronic pain, training, and the future of psychedelic therapy

(59:10)

Numinus Completes Novamind Acquisition | CEO Payton Nyquvest

(14:13)

Numinus Wellness CEO Interview

(28:16)

Are Psychedelics A Viable Industry? | Numinus

(9:59)

Numinus To Administer First Psilocybin Therapy | CEO Payton Nyquvest

(13:55)

CEO: Numinus (CSE: NUMI) Payton Nyquvest

(13:46)